Evaluate the following clinical research scenarios and match each to the specific epidemiological phenomenon or bias it most accurately represents.
- In a 5-year longitudinal trial of a demanding intensive lifestyle intervention for type 2 diabetes, 45% of intervention subjects drop out compared to 10% of controls. Per-protocol analysis of the remaining subjects demonstrates a massive reduction in HbA1c.Attrition bias
- A case-control study evaluates the link between chronic NSAID use and renal cell carcinoma. Researchers select both the cases and the controls exclusively from admitted patients on a general medical ward, spuriously altering the exposure odds.Berkson bias
- A novel rapid biomarker for suspected pulmonary embolism is evaluated. Only patients testing positive for the biomarker proceed to receive the gold-standard CT pulmonary angiography, while negative patients are discharged without advanced imaging.Verification bias
- A trial evaluating a biologic for asthma shows an overall relative risk of exacerbation of 0.85. Stratified analysis reveals a relative risk of 0.40 in patients with high baseline eosinophils and 1.05 in those with normal eosinophils.Effect modification
Answer
The correct matches are: 1) The diabetes dropout scenario represents Attrition bias. 2) The hospitalized control scenario represents Berkson bias. 3) The biomarker screening scenario represents Verification bias. 4) The asthma biologic stratum-specific scenario represents Effect modification.
Each scenario perfectly illustrates a classic epidemiological principle: differential loss to follow-up defines attrition bias; hospital-based control selection defines Berkson bias; non-random application of a diagnostic gold standard defines verification bias; and differential treatment effects across physiological subgroups defines effect modification.
Step-by-Step Solution
Key Concept
Differentiating specific subtypes of selection bias (Attrition, Berkson), information bias (Verification), and epidemiological phenomena (Effect modification) in clinical research.